People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cepheid | — | Biotechnology | Series A | $5.2M | $188.0M | 2012 |
Dean H. Morton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dean H. Morton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph H. Smith | 1 | 3 |
| Robert J. Easton | 1 | 2 |
| Glenn D. Steele | 1 | 2 |
| Hollings C. Renton | 1 | 2 |
| Thomas D. Brown | 1 | 2 |
| David H. Persing | 1 | 1 |
| Thomas L. Gutshall | 1 | 1 |
| Kerry H. Flom | 1 | 1 |
| Cristina H. Kepner | 1 | 1 |
| Andrew L. Miller | 1 | 1 |
| John L. Bishop | 1 | 1 |
| Humberto H. Reyes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.